Strategic Alliances in Knowledge-Intensive Industries: An Integrated View
In this study, we examine strategic alliances between large pharmaceutical companies (LPCs) and new biotechnology firms (NBFs) in the knowledge-intensive biopharmaceutical industry in the light of two explanations for the motives behind R&D alliances, namely, the transaction cost explanation and the learning with flexibility explanation. We develop a series of propositions based on an integrated view of the motives behind strategic alliances in knowledge-based industries.
strategic alliances, R&D, transaction cost economics, learning, biotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.